Brain Science

Politico – November 29, 2017

Researchers from The Feinstein Institute for Medical Research discovered dozens of new genetic variations associated with cognition, according to a study in Cell Reports. “For the first time, we were able to use genetic information to point us towards specific drugs that might aid in cognitive disorders of the brain, including Alzheimer’s disease, schizophrenia and attention deficit hyperactivity disorder,” Dr. Todd Lencz, senior author of the study and professor at the Feinstein Institute. Read more about it here.